Company Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.

The company is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd.

Country	Israel
Founded	2015
Industry	Biotechnology
Sector	Healthcare
Employees	121
CEO	Uzi Sofer

Contact Details

Address: Kiryat HaMada St. 5 Jerusalem, 9777605 Israel
Phone	972 3 577 4115
Website	alphatau.com

Stock Details

Ticker Symbol	DRTS
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	1871321
CUSIP Number	M0740A108
ISIN Number	IL0011839383
SIC Code	3841

Key Executives

Name	Position
Uzi Sofer	Chief Executive Officer and Chairman
Raphi Levy	Chief Financial Officer
Amnon Gat	Chief Operations Officer
Ronen Segal	Chief Technology Officer
Dr. Robert B. Den M.D.	Chief Medical Officer and Member of Scientific Advisory Board
Prof. Yona Keisari	Chief Scientific Officer and Member of Scientific Advisory board
Rebecca Becker	Vice President of legal
Yael Zeiger	Corporate Controller

Latest SEC Filings

Date	Type	Title
May 11, 2026	6-K	Report of foreign issuer
May 11, 2026	6-K	Report of foreign issuer
May 8, 2026	6-K	Report of foreign issuer
May 8, 2026	6-K	Report of foreign issuer
May 7, 2026	6-K	Report of foreign issuer
May 5, 2026	6-K	Report of foreign issuer
May 4, 2026	6-K	Report of foreign issuer
May 1, 2026	EFFECT	Notice of Effectiveness
Apr 28, 2026	F-3	Filing
Apr 27, 2026	6-K	Report of foreign issuer

View All SEC Filings